STAT

Opinion: Lobotomies were once used to treat this gut disease, part of a shameful medical history

I am searching for "patient zero," the first person to be given a barbaric lobotomy to "cure" her ulcerative colitis. Can you help me find her?
Source: Wellcome Images

In May 1951, a 35-year-old Boston woman who had been treated for years for ulcerative colitis and a variety of mental disorders — with little success — entered the Lahey Clinic in Burlington, Mass., to have a lobotomy. Her doctors drilled two holes into her skull and cut or melted away two wedges of her brain’s cerebral cortex using a technique developed by James Poppen, a Lahey neurosurgeon.

By August, according to Walter I. Tucker, a Lahey psychiatrist, she was largely free of her physical and mental ailments. By December, after a period of confusion and “laziness,” she was socially active and going to dances, Tucker wrote in the Lahey Clinic Bulletin. She was also gaining weight and working regularly, and was free of “inappropriate worries, phobias, obsessions, and compulsions.” There was no sign of colitis. Her mother, with whom she lived, “was amazed at the change and thinks that the patient is better than she has ever been in her life,” Tucker wrote.

Like most patients in medical history, we don’t know her name. And we have no idea whether she went on to live

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks